HEADER TRANSFERASE 10-FEB-22 7R59 TITLE PARP2 CATALYTIC DOMAIN IN COMPLEX WITH OUL245 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PARP-2,HPARP-2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE COMPND 5 2,ARTD2,DNA ADP-RIBOSYLTRANSFERASE PARP2,NAD(+) ADP- COMPND 6 RIBOSYLTRANSFERASE 2,ADPRT-2,POLY[ADP-RIBOSE] SYNTHASE 2,PADPRT-2, COMPND 7 PROTEIN POLY-ADP-RIBOSYLTRANSFERASE PARP2; COMPND 8 EC: 2.4.2.30,2.4.2.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP2, ADPRT2, ADPRTL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, PARP, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.GALERA-PRAT,M.M.MAKSIMAINEN,L.LEHTIO REVDAT 3 07-FEB-24 7R59 1 REMARK REVDAT 2 08-FEB-23 7R59 1 JRNL REVDAT 1 25-JAN-23 7R59 0 JRNL AUTH S.MURTHY,M.G.NIZI,M.M.MAKSIMAINEN,S.MASSARI,J.ALAVIUHKOLA, JRNL AUTH 2 B.E.LIPPOK,C.VAGAGGINI,S.T.SOWA,A.GALERA-PRAT,Y.ASHOK, JRNL AUTH 3 H.VENKANNAGARI,R.PRUNSKAITE-HYYRYLAINEN,E.DREASSI,B.LUSCHER, JRNL AUTH 4 P.KORN,O.TABARRINI,L.LEHTIO JRNL TITL [1,2,4]TRIAZOLO[3,4- B ]BENZOTHIAZOLE SCAFFOLD AS VERSATILE JRNL TITL 2 NICOTINAMIDE MIMIC ALLOWING NANOMOLAR INHIBITION OF JRNL TITL 3 DIFFERENT PARP ENZYMES. JRNL REF J.MED.CHEM. V. 66 1301 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 36598465 JRNL DOI 10.1021/ACS.JMEDCHEM.2C01460 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 22705 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1195 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1654 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.83 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.3360 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2757 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 19 REMARK 3 SOLVENT ATOMS : 199 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.18000 REMARK 3 B22 (A**2) : -0.78000 REMARK 3 B33 (A**2) : 0.96000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.200 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.175 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.131 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.897 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2844 ; 0.009 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2714 ; 0.001 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3840 ; 1.494 ; 1.644 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6270 ; 1.328 ; 1.577 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 348 ; 6.892 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 143 ;34.463 ;22.867 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 520 ;15.693 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;17.557 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 360 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3193 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 629 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7R59 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1292120962. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-OCT-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23900 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.40 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4TVJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 9.5 AND 20% PEG 3350, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.19000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.34500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.91000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.34500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.19000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.91000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 580 REMARK 465 GLN A 581 REMARK 465 LEU A 582 REMARK 465 TRP A 583 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 294 -144.43 -88.16 REMARK 500 HIS A 394 51.46 -116.63 REMARK 500 LYS A 480 75.29 -111.56 REMARK 500 ALA A 501 136.26 -37.51 REMARK 500 ARG A 570 -42.88 -139.65 REMARK 500 REMARK 500 REMARK: NULL DBREF 7R59 A 235 583 UNP Q9UGN5 PARP2_HUMAN 235 583 SEQADV 7R59 SER A 233 UNP Q9UGN5 EXPRESSION TAG SEQADV 7R59 MET A 234 UNP Q9UGN5 EXPRESSION TAG SEQADV 7R59 HIS A 447 UNP Q9UGN5 PRO 447 ENGINEERED MUTATION SEQRES 1 A 351 SER MET ASP LEU ARG VAL GLN GLU LEU ILE LYS LEU ILE SEQRES 2 A 351 CYS ASN VAL GLN ALA MET GLU GLU MET MET MET GLU MET SEQRES 3 A 351 LYS TYR ASN THR LYS LYS ALA PRO LEU GLY LYS LEU THR SEQRES 4 A 351 VAL ALA GLN ILE LYS ALA GLY TYR GLN SER LEU LYS LYS SEQRES 5 A 351 ILE GLU ASP CYS ILE ARG ALA GLY GLN HIS GLY ARG ALA SEQRES 6 A 351 LEU MET GLU ALA CYS ASN GLU PHE TYR THR ARG ILE PRO SEQRES 7 A 351 HIS ASP PHE GLY LEU ARG THR PRO PRO LEU ILE ARG THR SEQRES 8 A 351 GLN LYS GLU LEU SER GLU LYS ILE GLN LEU LEU GLU ALA SEQRES 9 A 351 LEU GLY ASP ILE GLU ILE ALA ILE LYS LEU VAL LYS THR SEQRES 10 A 351 GLU LEU GLN SER PRO GLU HIS PRO LEU ASP GLN HIS TYR SEQRES 11 A 351 ARG ASN LEU HIS CYS ALA LEU ARG PRO LEU ASP HIS GLU SEQRES 12 A 351 SER TYR GLU PHE LYS VAL ILE SER GLN TYR LEU GLN SER SEQRES 13 A 351 THR HIS ALA PRO THR HIS SER ASP TYR THR MET THR LEU SEQRES 14 A 351 LEU ASP LEU PHE GLU VAL GLU LYS ASP GLY GLU LYS GLU SEQRES 15 A 351 ALA PHE ARG GLU ASP LEU HIS ASN ARG MET LEU LEU TRP SEQRES 16 A 351 HIS GLY SER ARG MET SER ASN TRP VAL GLY ILE LEU SER SEQRES 17 A 351 HIS GLY LEU ARG ILE ALA HIS PRO GLU ALA PRO ILE THR SEQRES 18 A 351 GLY TYR MET PHE GLY LYS GLY ILE TYR PHE ALA ASP MET SEQRES 19 A 351 SER SER LYS SER ALA ASN TYR CYS PHE ALA SER ARG LEU SEQRES 20 A 351 LYS ASN THR GLY LEU LEU LEU LEU SER GLU VAL ALA LEU SEQRES 21 A 351 GLY GLN CYS ASN GLU LEU LEU GLU ALA ASN PRO LYS ALA SEQRES 22 A 351 GLU GLY LEU LEU GLN GLY LYS HIS SER THR LYS GLY LEU SEQRES 23 A 351 GLY LYS MET ALA PRO SER SER ALA HIS PHE VAL THR LEU SEQRES 24 A 351 ASN GLY SER THR VAL PRO LEU GLY PRO ALA SER ASP THR SEQRES 25 A 351 GLY ILE LEU ASN PRO ASP GLY TYR THR LEU ASN TYR ASN SEQRES 26 A 351 GLU TYR ILE VAL TYR ASN PRO ASN GLN VAL ARG MET ARG SEQRES 27 A 351 TYR LEU LEU LYS VAL GLN PHE ASN PHE LEU GLN LEU TRP HET GOL A 601 6 HET I5F A 602 13 HETNAM GOL GLYCEROL HETNAM I5F [1,2,4]TRIAZOLO[3,4-B][1,3]BENZOTHIAZOL-6-OL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GOL C3 H8 O3 FORMUL 3 I5F C8 H5 N3 O S FORMUL 4 HOH *199(H2 O) HELIX 1 AA1 ASP A 235 CYS A 246 1 12 HELIX 2 AA2 ASN A 247 MET A 258 1 12 HELIX 3 AA3 PRO A 266 LEU A 270 5 5 HELIX 4 AA4 THR A 271 GLY A 292 1 22 HELIX 5 AA5 HIS A 294 ILE A 309 1 16 HELIX 6 AA6 THR A 323 VAL A 347 1 25 HELIX 7 AA7 HIS A 356 LEU A 365 1 10 HELIX 8 AA8 SER A 376 THR A 389 1 14 HELIX 9 AA9 GLY A 411 PHE A 416 1 6 HELIX 10 AB1 ARG A 431 SER A 433 5 3 HELIX 11 AB2 ASN A 434 GLY A 442 1 9 HELIX 12 AB3 PRO A 451 TYR A 455 5 5 HELIX 13 AB4 MET A 466 ASN A 472 1 7 HELIX 14 AB5 TYR A 473 PHE A 475 5 3 HELIX 15 AB6 SER A 525 PHE A 528 5 4 HELIX 16 AB7 ASN A 563 ASN A 565 5 3 SHEET 1 AA1 5 CYS A 367 PRO A 371 0 SHEET 2 AA1 5 THR A 398 LYS A 409 -1 O GLU A 406 N ARG A 370 SHEET 3 AA1 5 VAL A 567 ASN A 578 -1 O ASN A 578 N THR A 398 SHEET 4 AA1 5 THR A 482 ALA A 491 -1 N LEU A 485 O LEU A 573 SHEET 5 AA1 5 ARG A 423 GLY A 429 -1 N HIS A 428 O LEU A 486 SHEET 1 AA2 4 ILE A 461 PHE A 463 0 SHEET 2 AA2 4 GLU A 558 VAL A 561 -1 O VAL A 561 N ILE A 461 SHEET 3 AA2 4 SER A 514 GLY A 517 -1 N GLY A 517 O GLU A 558 SHEET 4 AA2 4 CYS A 495 LEU A 498 1 N ASN A 496 O SER A 514 SHEET 1 AA3 3 ALA A 541 ASP A 543 0 SHEET 2 AA3 3 GLY A 519 PRO A 523 -1 N ALA A 522 O SER A 542 SHEET 3 AA3 3 LEU A 554 TYR A 556 1 O LEU A 554 N LYS A 520 SHEET 1 AA4 2 VAL A 529 LEU A 531 0 SHEET 2 AA4 2 SER A 534 VAL A 536 -1 O VAL A 536 N VAL A 529 CISPEP 1 GLY A 539 PRO A 540 0 3.35 CRYST1 58.380 67.820 86.690 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017129 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014745 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011535 0.00000